Synvista Therapeutics Inc (SYNI)

[J.T. The DD King]

Below is information and statement from the ASCO convention indicating Dr. Noah Berkowitz and a speaker with regards to PEG-SN38 aka SYI-2074 and a new link indicating the PEG-SN38 was presented at 2012 Advances in Neuroblastoma Research Conference last week. (ANR2012)

7. Monday, June 4, 1:15-5:15pm, E450b, Poster Board #9
Discussion: 4:45-5:45pm, N Hall B1

Final analysis of phase II study of ??? 2208 (PEG-SN38) in metastatic breast cancer (MBC).

Cynthia R. C. Osborne, Joyce O'Shaughnessy, Frankie Ann Holmes, Hyun Sue Kim, Darren M. Kocs, Michael S. Steinberg, Paul D. Richards, Svetislava J. Vukelja, Noah C. Berkowitz, Aby Buchbinder

Here is the link to a news release for the ANR-2012 so there is a lot of buzz out there right now that hasn't been mentioned in years!--> http://investor.enzon.com/releasedetail.cfm?ReleaseID=684289

Taking into consideration Mary Tanner still sits on the BOD at Synvista and even though Synvista appears to be a shell, the shareholders have a claim to ownership of the royalties from PEG-SN38. Dr. Berkowitz just can't take property owned by Synvista over to Enzon and say "Here Ya go!". I'm confidant Enzon would never leave that loose string of that magnitude untied so a R/M is imminent!

Finally Mary Tanner not only is on Synvista's BOD but she works for Peter Soloman in mergers and acquisitions. Does anyone think she's just going to stand by and watch Enzon take her blood, sweat and tears to market while standing on the sidelines?

http://www.mckesson.com/en_us/McKesson.com/About%2BUs/Newsroom/Press%2BReleases%2BArchives/2012/US%2BOncology%2BResearch%2526%252344%253B%2BThe%2BUS%2BOncology%2BNetwork%2Band%2BMcKesson%2BSpecialty%2BHealth%2BAffiliated%2BInvestigators%2BParticipate%2Bin%2BStudies%2BFeatured%2Bat%2BASCO%2B2012.html